— Know what they know.
Not Investment Advice
Also trades as: 0H7R.L (LSE) · $vol 0M

ABEO NASDAQ

Abeona Therapeutics Inc.
1W: -1.4% 1M: -1.9% 3M: +4.9% YTD: +4.0% 1Y: -14.0% 3Y: +82.2% 5Y: -84.0%
$5.44
-0.08 (-1.45%)
 
Weekly Expected Move ±7.0%
$5 $5 $5 $6 $6
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 43 · $310.1M mcap · 36M float · 3.43% daily turnover · Short 58% of daily vol

📊 Key Metrics

TTM
$15M
Revenue
+0.0% YoY
$66M
Net Income
+249.7% YoY
$-85M
Free Cash Flow
-35.3% YoY
59.1%
Gross Margin
-264.1%
Op. Margin
-195.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE65.1%
ROA40.3%
ROIC1282.7%

Valuation

P/E4.7
P/B2.1
EV/EBITDA1.3

Leverage

Debt/Equity0.16
Current Ratio6.93
Interest Cov.17.6x

Quality Scores

Piotroski F5/9
Altman Z-0.24
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms